LLY

1,003.75

-0.1%↓

JNJ

245.32

-0.54%↓

ABBV

235.99

+1.04%↑

NVS

165.01

+0.53%↑

AZN

201.13

+0.17%↑

LLY

1,003.75

-0.1%↓

JNJ

245.32

-0.54%↓

ABBV

235.99

+1.04%↑

NVS

165.01

+0.53%↑

AZN

201.13

+0.17%↑

LLY

1,003.75

-0.1%↓

JNJ

245.32

-0.54%↓

ABBV

235.99

+1.04%↑

NVS

165.01

+0.53%↑

AZN

201.13

+0.17%↑

LLY

1,003.75

-0.1%↓

JNJ

245.32

-0.54%↓

ABBV

235.99

+1.04%↑

NVS

165.01

+0.53%↑

AZN

201.13

+0.17%↑

LLY

1,003.75

-0.1%↓

JNJ

245.32

-0.54%↓

ABBV

235.99

+1.04%↑

NVS

165.01

+0.53%↑

AZN

201.13

+0.17%↑

Home・Aandelen Lijst・Celsion Corp

Celsion Corp

Gesloten

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

Max

Belangrijke statistieken
By Trading Economics
Werknemers	25

Aanbevelingen
By TipRanks
Aanbevelingen	Buy
12 Maanden Prognose	+666.87% upside

Marktinformatie
By TradingEconomics
Marktkapitalisatie	938K
Vorige openingsprijs	0
Vorige sluitingsprijs	0

Celsion Corp Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

4 mrt 2026, 23:39 UTC

Populaire aandelen

Stocks to Watch: Broadcom, StubHub, PepGen, Veeva Systems

4 mrt 2026, 23:20 UTC

Winsten

Broadcom Sales Rise as AI Developers Build More Products and Agents -- Update

4 mrt 2026, 21:43 UTC

Winsten

Broadcom Logs Higher Sales, Authorizes $10 Billion Buyback Amid Climbing AI Demand

4 mrt 2026, 23:48 UTC

Marktinformatie

Nikkei May Rise After Recent Selloffs -- Market Talk

4 mrt 2026, 23:33 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Gold Edges Higher Amid Ongoing U.S.-Iran Conflict -- Market Talk

4 mrt 2026, 23:24 UTC

Marktinformatie

RBA on Track to Raise Rates, but What's the Rush? -- Market Talk

4 mrt 2026, 22:30 UTC

Winsten

Ecopetrol: Distribution Equivalent to a Payout of 50.1% of Ecopetrol S.A.'s Net Income in 2025 >EC

4 mrt 2026, 22:30 UTC

Winsten

Ecopetrol: Payment of Dividends Proposed to Be Made No Later Than April 30 >EC

4 mrt 2026, 22:30 UTC

Winsten

Ecopetrol: Earnings Distribution Proposes Ordinary Div Distribution of COP110 per Shr >EC

4 mrt 2026, 22:13 UTC

Winsten

Vermilion Energy: Expects Full-Yr Production of 118,000 to 122,000 Boe/d (70% Natural Gas) >VET

4 mrt 2026, 22:13 UTC

Winsten

Vermilion Energy: Expects 1Q Production to Avg 122,000 to 124,000 Boe/d (70% Natural Gas) >VET

4 mrt 2026, 22:13 UTC

Winsten

Vermilion Energy 4Q EPS C$2.86 >VET

4 mrt 2026, 22:04 UTC

Marktinformatie

RBA Slipping Behind The Curve On Rates -- Market Talk

4 mrt 2026, 21:53 UTC

Winsten

Lithium Americas 4Q Rev $66.8M >LAC

4 mrt 2026, 21:53 UTC

Winsten

Lithium Americas 4Q Loss/Shr 52c >LAC

4 mrt 2026, 21:52 UTC

Winsten

Broadcom Earnings Beat Estimates as AI Demand Remains Strong -- Barrons.com

4 mrt 2026, 21:50 UTC

Winsten

These Stocks Are Today's Movers: Moderna, Coinbase, Strategy, CoreWeave, Micron, Sandisk, GitLab, and More -- Barrons.com

4 mrt 2026, 21:50 UTC

Marktinformatie

Tech, Media & Telecom Roundup: Market Talk

4 mrt 2026, 21:48 UTC

Winsten

Webull 4Q Rev $165.2M >BULL

4 mrt 2026, 21:48 UTC

Winsten

Webull 4Q EPS 1c >BULL

4 mrt 2026, 21:45 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

4 mrt 2026, 21:45 UTC

Marktinformatie

Canada Officials Might Need to Intervene to Spur Home Building -- Market Talk

4 mrt 2026, 21:40 UTC

Winsten

Broadcom Earnings Beat Estimates as AI Demand Remains Strong -- Barrons.com

4 mrt 2026, 21:36 UTC

Belangrijke Nieuwsgebeurtenissen

Iran Conflict Spurs Rebound in U.S. Borrowing Costs -- Update

4 mrt 2026, 21:27 UTC

Winsten

Broadcom Earnings Beat Estimates as AI Demand Remains Strong -- Barrons.com

4 mrt 2026, 21:17 UTC

Marktinformatie

Energy Price Volatility Boosts Case for Climate-Tech Startups -- Market Talk

4 mrt 2026, 21:16 UTC

Winsten

Broadcom: Board Authorizes Share-Repurchase Program for Up to $10B of Common Stock >AVGO

4 mrt 2026, 21:15 UTC

Winsten

Broadcom 1Q EPS $1.50 >AVGO

4 mrt 2026, 21:15 UTC

Winsten

Broadcom 1Q Net $7.35B >AVGO

4 mrt 2026, 21:15 UTC

Winsten

Broadcom 1Q Rev $19.31B >AVGO

Peer Vergelijking

Prijswijziging

Celsion Corp Prognose

Koersdoel

By TipRanks

666.87% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 25 USD 666.87%

Hoogste 25 USD

Laagste 25 USD

Gebaseerd op 1 Wall Street-analisten die 12-maands prijsdoelen bieden voor Celsion Corp - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

1 ratings

Buy

Hold

Sell

Gebaseerd op 1 analisten die aandelenratings hebben gegeven aan Celsion Corp - Dist in de afgelopen 3 maanden.

Financieel

Over Celsion Corp

Imunon, Inc., a clinical-stage biotechnology company, engages in the development of immunotherapies and vaccines to treat cancer and infectious diseases. The company's lead clinical program IMNN-001, a DNA-based immunotherapy for the localized treatment of ovarian cancer that is in Phase II clinical development. Its preclinical stage products include IMNN-101, a COVID-19 booster vaccine; IMNN-102 for the treatment of Lassa virus; and IMNN-201, a Trp2 tumor associated antigen cancer vaccine in melanoma. In addition, the company develops non-viral DNA technology across four modalities, such as TheraPlas for the coding of proteins and cytokines in the treatment of solid tumors; PlaCCine for the coding of viral antigens that can elicit a strong immunological response; FixPlas for the application of Imunon's DNA technology to produce universal cancer vaccines; and IndiPlas, which is in the discovery phase for the development of personalized cancer vaccines or neoepitope cancer vaccines. Imunon, Inc. was formerly known as Celsion Corporation and changed its name to Imunon, Inc. in September 2022. The company was founded in 1982 and is headquartered in Lawrenceville, New Jersey.